Sarepta Therapeutics (SRPT) Free Cash Flow (QoQ) (2010 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -260.45% |
| Dec 31, 2025 | 440.13% |
| Sep 30, 2025 | -116.35% |
| Jun 30, 2025 | 136.60% |
| Mar 31, 2025 | -1,262.05% |
| Dec 31, 2024 | 149.98% |
| Sep 30, 2024 | -658.96% |
| Jun 30, 2024 | 94.82% |
| Mar 31, 2024 | -272.50% |
| Dec 31, 2023 | 48.96% |
| Sep 30, 2023 | -3.02% |
| Jun 30, 2023 | 35.97% |
| Mar 31, 2023 | -118.10% |
| Dec 31, 2022 | -37.11% |
| Sep 30, 2022 | 3.56% |
| Jun 30, 2022 | 28.89% |
| Mar 31, 2022 | -238.47% |
| Dec 31, 2021 | 76.39% |
| Sep 30, 2021 | -16.11% |
| Jun 30, 2021 | 42.91% |
| Mar 31, 2021 | 0.80% |
| Dec 31, 2020 | 22.90% |
| Sep 30, 2020 | -107.84% |
| Jun 30, 2020 | -120.49% |
| Mar 31, 2020 | 441.71% |
| Dec 31, 2019 | -135.56% |
| Sep 30, 2019 | 19.67% |
| Jun 30, 2019 | 41.11% |
| Mar 31, 2019 | -13.93% |
| Dec 31, 2018 | -6.91% |
| Sep 30, 2018 | -5.92% |
| Jun 30, 2018 | -163.31% |
| Mar 31, 2018 | -36.84% |
| Dec 31, 2017 | 40.42% |
| Sep 30, 2017 | 33.35% |
| Jun 30, 2017 | -41.16% |
| Mar 31, 2017 | 25.90% |
| Dec 31, 2016 | -36.92% |
| Sep 30, 2016 | -40.62% |
| Jun 30, 2016 | 29.35% |
| Mar 31, 2016 | -91.17% |
| Dec 31, 2015 | 31.82% |
| Sep 30, 2015 | -62.72% |
| Jun 30, 2015 | 33.53% |
| Mar 31, 2015 | -53.49% |
| Dec 31, 2014 | 40.17% |
| Sep 30, 2014 | -8.56% |
| Jun 30, 2014 | -31.04% |
| Mar 31, 2014 | -82.26% |
| Dec 31, 2013 | 13.09% |
| Sep 30, 2013 | -70.62% |
| Jun 30, 2013 | 17.16% |
| Mar 31, 2013 | -109.58% |
| Dec 31, 2012 | 7.88% |
| Sep 30, 2012 | -33.60% |
| Jun 30, 2012 | 35.79% |
| Mar 31, 2012 | -54.76% |
| Dec 31, 2011 | 25.15% |
| Sep 30, 2011 | -777.67% |
| Jun 30, 2011 | 91.34% |
| Mar 31, 2011 | -392.02% |
| Dec 31, 2010 | 31.66% |